Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLC
Clinical trial NCT02474355 · COMPLETED
Trial details
- NCT number
- NCT02474355
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-18
- Primary completion
- 2019-04-18
- Enrollment
- 3017
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.